A polygenic score associated with fracture risk in breast cancer patients treated with aromatase inhibitors.
A polygenic score associated with fracture risk in breast cancer patients treated with aromatase inhibitors. NPJ Breast Cancer. 2024 Jan 20; 10(1):9.